A Study of Different Particle Sizes of Evacetrapib in Healthy Participants
NCT02497391
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Evacetrapib
Sponsor
Eli Lilly and Company